CN110218733A - Utilize the method for ccdB lethal gene rapid build recombinant plasmid - Google Patents
Utilize the method for ccdB lethal gene rapid build recombinant plasmid Download PDFInfo
- Publication number
- CN110218733A CN110218733A CN201910382063.0A CN201910382063A CN110218733A CN 110218733 A CN110218733 A CN 110218733A CN 201910382063 A CN201910382063 A CN 201910382063A CN 110218733 A CN110218733 A CN 110218733A
- Authority
- CN
- China
- Prior art keywords
- ccdb
- gene
- expression cassettes
- recombinant plasmid
- pcr product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 101150102092 ccdB gene Proteins 0.000 title claims abstract description 70
- 239000013612 plasmid Substances 0.000 title claims abstract description 40
- 238000000034 method Methods 0.000 title claims abstract description 34
- 108700005090 Lethal Genes Proteins 0.000 title claims abstract description 20
- 239000013598 vector Substances 0.000 claims abstract description 25
- 241000894006 Bacteria Species 0.000 claims abstract description 13
- 230000006801 homologous recombination Effects 0.000 claims abstract description 13
- 238000002744 homologous recombination Methods 0.000 claims abstract description 13
- 108090000623 proteins and genes Proteins 0.000 claims description 53
- 230000014509 gene expression Effects 0.000 claims description 48
- 108020004414 DNA Proteins 0.000 claims description 30
- 239000013604 expression vector Substances 0.000 claims description 25
- 230000003321 amplification Effects 0.000 claims description 15
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 15
- YRMCBQLZVBXOSJ-PCFSSPOYSA-N (e)-3-[(6r,6as)-4-hydroxy-6-methoxy-3-methyl-11-oxo-5,6,6a,7-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]prop-2-enamide Chemical compound CO[C@H]1NC2=C(O)C(C)=CC=C2C(=O)N2C=C(\C=C\C(N)=O)C[C@@H]12 YRMCBQLZVBXOSJ-PCFSSPOYSA-N 0.000 claims description 8
- 230000003115 biocidal effect Effects 0.000 claims description 8
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 6
- 229960005091 chloramphenicol Drugs 0.000 claims description 5
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 claims description 5
- 239000001963 growth medium Substances 0.000 claims description 5
- 238000012408 PCR amplification Methods 0.000 claims description 4
- 241000588724 Escherichia coli Species 0.000 claims description 3
- 238000012217 deletion Methods 0.000 claims description 2
- 230000037430 deletion Effects 0.000 claims description 2
- 239000013613 expression plasmid Substances 0.000 claims description 2
- 239000000284 extract Substances 0.000 claims description 2
- 238000003259 recombinant expression Methods 0.000 claims description 2
- 238000010276 construction Methods 0.000 abstract description 5
- 238000012216 screening Methods 0.000 abstract description 3
- 230000002255 enzymatic effect Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 description 27
- 101150094267 mqo gene Proteins 0.000 description 12
- 125000004122 cyclic group Chemical group 0.000 description 10
- 238000005516 engineering process Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 6
- 238000000246 agarose gel electrophoresis Methods 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 239000013600 plasmid vector Substances 0.000 description 4
- 238000013461 design Methods 0.000 description 3
- 238000013467 fragmentation Methods 0.000 description 3
- 238000006062 fragmentation reaction Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical class O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 230000009465 prokaryotic expression Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- 238000011238 DNA vaccination Methods 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010362 genome editing Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910382063.0A CN110218733A (en) | 2019-05-08 | 2019-05-08 | Utilize the method for ccdB lethal gene rapid build recombinant plasmid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910382063.0A CN110218733A (en) | 2019-05-08 | 2019-05-08 | Utilize the method for ccdB lethal gene rapid build recombinant plasmid |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110218733A true CN110218733A (en) | 2019-09-10 |
Family
ID=67820770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910382063.0A Pending CN110218733A (en) | 2019-05-08 | 2019-05-08 | Utilize the method for ccdB lethal gene rapid build recombinant plasmid |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110218733A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108588101A (en) * | 2018-04-27 | 2018-09-28 | 四川大学 | Build the molecular cloning method of same gene difference expression vector |
-
2019
- 2019-05-08 CN CN201910382063.0A patent/CN110218733A/en active Pending
Non-Patent Citations (2)
Title |
---|
HAILONG WANG: "Improved seamless mutagenesis by recombineering using ccdB for counterselection", 《NUCLEIC ACIDS RESEARCH》 * |
JUDITH SCHOLZ: "A new method to customize protein expression vectors for fast, efficient and background free parallel cloning", 《BMC BIOTECHNOLOGY》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108588101A (en) * | 2018-04-27 | 2018-09-28 | 四川大学 | Build the molecular cloning method of same gene difference expression vector |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5460954A (en) | Production of human proinsulin using a novel vector system | |
CN105238806B (en) | A kind of building and its application of the CRISPR/Cas9 gene editing carrier for microorganism | |
RU2094439C1 (en) | Recombinant polypeptide pgh(a) with n-terminal alanine | |
CN1818070A (en) | Methods of manipulating and sequencing nucleic acid molecules using transposition and recombination | |
CN109486847B (en) | Bacillus subtilis efficient induction expression system based on artificial tandem promoter | |
CN110218733A (en) | Utilize the method for ccdB lethal gene rapid build recombinant plasmid | |
CN109385417A (en) | Internal DNA seamless integration method | |
US20060234336A1 (en) | Methylotrophic bacterium for the production of recombinant proteins and other products | |
WO2024099089A1 (en) | Genetically engineered strain for producing pseudouridine, construction method therefor and use thereof | |
CN112029699B (en) | Clostridium butyricum gene editing system based on endogenous CRISPR-Cas system and application thereof | |
CN116286931B (en) | Double-plasmid system for rapid gene editing of Ralstonia eutropha and application thereof | |
CN110305885A (en) | Utilize the kit of ccdB lethal gene rapid build recombinant plasmid | |
JPS58500590A (en) | Methods and vectors for controlled accumulation of cloned heterologous gene products in Bacillus subtilis | |
CN108486140A (en) | A kind of cloning vector preparation method and kit based on seamless clone technology | |
JPS61224991A (en) | Exclusive lyposome and its use | |
EP0048497A2 (en) | DNA transducing vector and microorganism containing it | |
CN108588101B (en) | Molecular cloning method for constructing different expression vectors of same gene | |
EP2109671B1 (en) | Expression cassette, use of the expression cassette, vector, host cell, a method for producing a polypeptide | |
KR100449639B1 (en) | Expression vector containing the promoter comprised of FIS binding sites, UP element and core promoter | |
CN113403243B (en) | Streptococcus suis luminescent bacterium based on lux report system and construction method thereof | |
WO1988006186A2 (en) | cDNAs ENCODING SOMATOTROPIN, EXPRESSION VECTORS AND HOSTS | |
CN112980842B (en) | Non-coding nucleotide sequence and application thereof in improving expression level of exogenous gene | |
CN110066821B (en) | Method for constructing random protein expression library based on random expression element multiplication mode | |
EP0309961A1 (en) | Plasmid vector containing streptomycin-sensitivity gene | |
CN117965587A (en) | Bacterial strain containing hok/sok genes and preparation and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20220127 Address after: 610000 No. 4, unit 3, building 11, No. 12, University Road, Wuhou District, Chengdu, Sichuan Applicant after: Sudan Address before: 610065, No. 24, south section of first ring road, Chengdu, Sichuan, Wuhou District Applicant before: SICHUAN University |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20220923 Address after: No. 304, 3rd Floor, Building 7, Sanyi Innovation Center (Phase III), No. 733, Section 2, Furong Avenue, Yongning Town, Wenjiang District, Chengdu City, Sichuan Province, China Applicant after: Chengdu Jujing Biotechnology Co.,Ltd. Address before: 610000 No. 4, unit 3, building 11, No. 12, University Road, Wuhou District, Chengdu, Sichuan Applicant before: Sudan |
|
TA01 | Transfer of patent application right |